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Summary
 
Propagation of signals from the T cell antigen receptor (TCR) involves a number of adaptor
molecules. SH2 domain–containing protein 76 (SLP-76) interacts with the guanine nucleotide
exchange factor Vav to activate the nuclear factor of activated cells (NF-AT), and its expression
is required for normal T cell development. We report the cloning and characterization of a
novel Grb2-like adaptor molecule designated as Grb2-related protein of the lymphoid system
(GrpL). Expression of GrpL is restricted to hematopoietic tissues, and it is distinguished from
Grb2 by having a proline-rich region. GrpL can be coimmunoprecipitated with SLP-76 but
not with Sos1 or Sos2 from Jurkat cell lysates. In contrast, Grb2 can be coimmunoprecipitated
with Sos1 and Sos2 but not with SLP-76. Moreover, tyrosine-phosphorylated LAT/pp36/38
in detergent lysates prepared from anti-CD3 stimulated T cells associated with Grb2 but not
GrpL. These data reveal the presence of distinct complexes involving GrpL and Grb2 in T cells.
A functional role of the GrpL–SLP-76 complex is suggested by the ability of GrpL to act alone
or in concert with SLP-76 to augment NF-AT activation in Jurkat T cells.
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L
 
igation of the T cell antigen receptor (TCR) complex
activates protein tyrosine kinases (PTKs)
 
1
 
 including the
Src family PTKs Fyn and Lck to phosphorylate immuno-
receptor tyrosine-based motifs (ITAMs) within associating
CD3 chains. This leads to the recruitment and activation of
the Syk family kinase ZAP-70 and possibly other proteins
such as Shc to phosphorylated CD3
 
z
 
. These activated PTKs
in turn phosphorylate a variety of proteins, and thereby
couple TCR ligation to a number of intracellular signaling
cascades culminating in T cell activation. Principal down-
stream substrates/effectors for TCR-activated PTKs have
been identified. They include phospholipase C-
 
g
 
1 (1-3), the
85-kD subunit of the phosphatidylinositol 3-kinase (4), the
src homology (SH)2 domain–containing leukocyte protein
of 76 kD (SLP-76) (5, 6), the proto-oncogene product Cbl
(5, 7), the Vav guanine nucleotide exchange factor (GEF) of
the Rho/Rac/CDC42 family of GTP-binding proteins (8,
9), and the recently cloned and characterized linker for ac-
tivation of T cells (LAT/pp36/38) (10–14). Functional in-
teractions between these phosphorylated effector molecules
are believed to be necessary for the operation of major
pathways required for T cell maturation including (a) intra-
cellular free Ca
 
2
 
1
 
 release, (b) activation of the nuclear fac-
tor of activated cells (NF-AT), and (c) mitogen-activated
protein kinase (MAPK) activation. These events ultimately
converge to induce gene expression, proliferation, or differ-
entiation of T cells (15–17).
SLP-76 is an essential adaptor molecule in T cells. When
it is tyrosine phosphorylated, probably by ZAP-70, SLP-76
may become a ligand for Vav (9, 18, 19). In Jurkat cells, the
tyrosine-phosphorylated SLP-76–Vav complex augments
TCR-induced activation of NF-AT, and hence expression
of IL-2 (9, 18–21). The in vivo function of SLP-76 in T
lineage cells is further illustrated by recent studies of SLP-76–
deficient mice. Mice deficient in SLP-76 expression show
profound defects in T cell development, and contain no
CD4/CD8 double positive thymocytes, resulting in a com-
plete loss of peripheral T cells (22, 23).
 
C.-L. Law, M.K. Ewings, and P.M. Chaudhary all contributed equally to
this study.
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Abbreviations used in this paper:
 
 GEF, guanine nucleotide exchange factor;
GrpL, Grb2-related protein of the lymphoid system; IP, immunoprecipi-
tate; MAPK, mitogen-activated protein kinase; NF-AT, nuclear factor of
activated T cells; PTK, protein tyrosine kinase; SH, src homology; SHP,
SH2 domain–containing protein tyrosine phosphatase; SLP-76, SH2 do-
main–containing leukocyte protein of 76 kD. 
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One connection between the TCR and SLP-76 may be
provided by Grb2 (24). The SH2 domain of Grb2 binds to
both Shc and LAT/pp36/38, allowing Grb2 to be localized
to the plasma membrane where most of the TCR-activated
PTKs are (13, 14, 25). The SH3 domain(s) of Grb2 bind to
Sos1 and Sos2 (GEF of the Ras family of GTP-binding pro-
tein) (26), SLP-76 (21, 27), and Cbl (7, 28, 29). The recruit-
ment of Sos to the plasma membrane by Grb2 initiates the
MAPK pathway, whereas the recruitment of SLP-76 (30),
Vav (8, 9), and Cbl (7, 31, 32) to the plasma membrane prob-
ably facilitates their phosphorylation by TCR-activated PTK.
The studies above suggest that Grb2 may function to
link multiple downstream effector molecules, e.g., SLP-76,
to LAT and possibly to the vicinity of the activated TCR
complex. However, more recent studies have revealed the
presence of an additional Grb2-like adaptor molecule,
Grap, which has the SH3-SH2-SH3 organization as Grb2
(33, 34). Interestingly, expression of Grap appears to be rel-
atively restricted to hematopoietic tissues (33, 34). Besides
binding to c-kit, the Bcr-Abl oncoprotein, and the erythro-
poietin receptor, Grap also interacts with LAT/pp36/38,
Sos, Shc, and phospholipase C-
 
g
 
1 in TCR-activated Jurkat
cells (33, 34). Exactly how Grb2 and Grap coordinate their
functions during TCR signaling remains to be elucidated.
In this paper, we report the molecular cloning and charac-
terization of another linker protein, which shares a number of
structural properties with Grb2 and Grap, yet differs from
them by having a proline-rich region. Since transcripts en-
coding this linker protein appear to be preferentially ex-
pressed in lymphoid cells, we have designated this protein
GrpL, for Grb2-related protein of the lymphoid system. GrpL
associates with different effector molecules than does Grb2 in
T cells and it regulates TCR-induced NF-AT activation.
 
Materials and Methods
 
Cells and Antibodies.
 
Various cell lines were maintained in stan-
dard culture media supplemented with 
 
l
 
-glutamine, nonessential
amino acids, sodium pyruvate, penicillin/streptomycin, and fetal
bovine serum. A rabbit anti–human (h)GrpL serum was generated
in this study against a His-Tag fusion protein containing the SH2
domain of hGrpL as described below. Antiphosphotyrosine 4G10
and anti-LAT/pp36/38 were purchased from Upstate Biotechnol-
ogy, Inc. Anti–SLP-76, anti-Grb2, anti–SH2 domain–containing
protein tyrosine phosphatase 2 (SHP-2), anti-Sos1, and anti-Sos2
were purchased from Santa Cruz Biotechnology. 64.1 (anti-CD3)
was provided by Dr. John Hansen (Fred Hutchinson Cancer Re-
search Center, Seattle, WA), C305 (anti-TCR) was provided by Dr.
G. Koretzky (University of Iowa, Iowa City, IA), and OKT3 (anti-
CD3) was obtained from the American Type Culture Collection.
 
Isolation of the Full-Length cDNA Clones Encoding Human and
Murine GrpL.
 
A full-length cDNA encoding hGrpL was identi-
fied through random sequencing of clones from a library pre-
pared from the acute myelogenous leukemia cell line KG-1a.
Overlapping partial cDNA clones encoding murine (m)GrpL were
isolated by low stringency reverse transcriptase (RT)-PCR using
multiple hGrpL-specific primer sets and murine splenic total
RNA as the template. RT-PCR at low annealing temperature
was performed according to the Titan™ One Tube RT-PCR
System protocol (Boehringer Mannheim Inc.). PCR products
were resolved on 1.5% agarose gels. cDNA bands corresponding
in sizes to the estimated lengths of hGrpL were excised from
the gel and eluded using the QIAEX II Gel Extraction Kit
(QIAGEN Inc.) according to the suppliers protocol. Isolated
cDNAs were then ligated into a T/A cloning vector (Invitrogen)
and transformed into competent 
 
E
 
.
 
 coli
 
 (Invitrogen). Recombi-
nant clones containing mGrpL inserts were selected by low strin-
gency hybridization to a hGrpL cDNA probe and then sequenced.
This allowed for the identification of primer sets specific for
mGrpL for the isolation of cDNA clones encoding both the 5
 
9
 
and 3
 
9
 
 ends of mGrpL by rapid amplification of cDNA ends. The
gene specific primers chosen were: 5
 
9
 
 cDNA end, 5
 
9
 
-CTG AGC
TTT CGC ACT GGA GAC ATT CTG; 3
 
9
 
 cDNA end, 5
 
9
 
-GCA
TCA GCG TGG CGT TCA CCT CAC TTC C.
The Marathon-Ready™ cDNA kit (Clontech Laboratory
Inc.) was used for RACE PCR and performed as recommended
by the supplier. The resulting PCR products were cloned into
T/A cloning vectors (Invitrogen) and sequenced.
 
Plasmid Constructs.
 
To generate the GrpL SH2 His-Tag fusion
protein, PCR was used to amplify a piece of cDNA encoding the
SH2 domains of GrpL using the full-length GrpL cDNA as tem-
plate and the following primer pairs: forward primer, 5
 
9
 
-GCG
GGG ATC CCC CAG TTT CCC AAA TGG TTT CAC; re-
verse primer, 5
 
9
 
-GCG GGG AAT TCC TCT GTC TCT AAG
GAA GAT CTG. Underlined nucleotides represent BamHI and
EcoRI sites in the forward and reverse primers, respectively.
PCR products were cut with these enzymes and ligated into
BamHI/EcoRI cut pET-28c(
 
1
 
) (Novagen, Inc.). To generate
the GST fusion construct, the insert from the His-Tag fusion
construct was cut out by BamHI/EcoRI and subcloned into
BamHI/EcoRI cut pGEX-5X-2 (Amersham Pharmacia Biotech).
The fusion protein constructs were then transformed into 
 
E
 
.
 
 coli
 
strain BL21(DE3) and induced with IPTG for protein production.
To generate the Myc-His tagged hGrpL expression plasmid
the coding region of hGrpL was amplified using the following
primer pairs: forward primer, 5
 
9
 
-CCT GAA GCT CGA GTC
GGG TCA TGG GTG CCA CGT A; reverse primer, 5
 
9
 
-GCG
GAA TTC GGA GGA TGG AAG CTG TTG CCA AGT TT.
Underlined nucleotides represent XhoI and EcoRI sites in the
forward and reverse primers, respectively. The PCR product was
cloned into the pcDNA3.1(
 
1
 
)/Myc-His A vector (Invitrogen),
in-frame with the c-Myc epitope and poly-His tags. The hGrpL-
Myc-His cassette was then excised with BamHI and PmeI and
subcloned into the pEF expression vector (provided by Dr. G.
Koretzky) at the BamHI and filled-in XbaI sites (pEF-GrpL). The
pEF–SLP-76 and the NF-AT luciferase reporter (NF-AT Luc)
constructs were also gifts from Dr. G. Koretzky.
 
Northern Blot Analysis and RT-PCR.
 
To detect GrpL message
in cell lines, 
 
z
 
30 
 
m
 
g of RNA were resolved on 1.2% morpholine
propanesulfonic acid (MOPS)/formaldehyde agarose gels, trans-
ferred onto GeneScreen Plus membranes (NEN™ Life Science
Products, Boston, MA), and fixed by UV cross-linking. Multiple
tissue Northern blots were obtained from Clontech. Northern
blots were prehybridized and hybridized to either the full-length
GrpL cDNA or 
 
b
 
-actin probes labeled with 
 
a
 
-[
 
32
 
P]dCTP
(NEN™ Life Science Products) according to the manufacturer’s
instructions. RT-PCR
 
 
 
was performed using the Titan™ One
Tube RT-PCR System (Boehringer Mannheim). The reaction
was carried out using 1 
 
m
 
g of total RNA and 20 nM forward and
reverse primers. Primers used were: forward primer, 5
 
9
 
-TGG
AAG CTG TTG CCA AGT TTG ATT TCA C; reverse primer,
5
 
9
 
-CTT CTC GGG TTC TGT CTC TAA GGA AG.  
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This primer set amplifies a 452-bp fragment containing the
NH
 
2
 
-terminal SH3 and the SH2 domains from cells expressing
GrpL message. The amount of total RNA used was monitored
by amplification of a 1-kb fragment encoding G3DPH using the
following primer set: forward primer, 5
 
9
 
-TGA AGG TCG GAG
TCA ACG GAT TTG GT; reverse primer, 5
 
9
 
-CAT GTG GGC
CAT GAG GTC CAC CAC. Cycling parameters PCR were pro-
grammed according to the instructions provided with the Titan™
system (Boehringer Mannheim).
 
T Cell Stimulation, Immuoprecipitation, and Immunoblot Analysis.
 
Jurkat T cells were pelleted and resuspended at 5–10 
 
3
 
 10
 
6
 
/ml in
medium. Cells were allowed to equilibrate at 37
 
8
 
C for 15 min
and then stimulated with either 5 or 10 
 
m
 
g/ml of anti-CD3 or
2.5 mM of H
 
2
 
O
 
2
 
 plus 250 
 
m
 
M of sodium orthovanadate (referred
to as pervanadate). Either class-matched antibodies or medium
only was used as control stimulus. Stimulation was terminated by
dilution of cell suspensions into 
 
.
 
10 vol of ice-cold PBS. Cells
were pelleted and lysed in a buffer containing 150 mM NaCl, 50
mM Tris, pH 8.0, 5 mM EDTA, 0.5% NP-40, protease inhibi-
tors (2 mM PMSF, 10 
 
m
 
g/ml aprotinin, 10 
 
m
 
g/ml leupeptin, and
1 
 
m
 
g/ml pepstatin), and phosphatase inhibitors (10 mM NaF,
1 mM Na
 
3
 
VO
 
4
 
, and 5 mM Na
 
4
 
P
 
2
 
O
 
7
 
). Lysates were clarified by
centrifugation before immunoprecipitation. Immunoprecipitation,
SDS-PAGE, and Western blot analysis were conducted as de-
scribed (35). Binding of primary antibodies to blots was detected
with horseradish peroxidase–conjugated secondary antibodies or
streptavidin (Jackson ImmunoResearch Labs.) and an enhanced
chemiluminescence kit (Amersham Pharmacia Biotech).
 
T Cell Transfection and Luciferase Assays.
 
Jurkat cells in log-
phase were washed with serum-free RPMI 1640 once and elec-
troporated in triplicate with a total of 60 
 
m
 
g of plasmid at 240 V,
960 
 
m
 
F using a Gene Pulser (Bio-Rad) at 10
 
7
 
 cells/400 
 
m
 
l serum-
free RPMI 1640. In general, 20 
 
m
 
g of NF-AT Luc were cotrans-
fected with either 20 
 
m
 
g of pEF, pEF–SLP-76, pEF-GrpL, or
pEF–SLP-76 plus pEF-GrpL. Sonicated salmon sperm DNA
(Sigma Chemical Co.) was used to maintain the total DNA at 60 
 
m
 
g
whenever necessary. After electroporation, cells were incubated
in fully supplemented RPMI 1640 for 14–18 h at 37
 
8
 
C, 5% CO
 
2
 
.
Cells were then transferred into 96-well plates at 2–5 
 
3
 
 10
 
5
 
 cells/
well in a total of 100 
 
m
 
l medium. Cells were stimulated in tripli-
cate with 1:500 dilution of C305 anti-CD3 for 6–8 h at 37
 
8
 
C.
Control cells were maintained in culture medium. After stimula-
tion, cells were lysed in 50–100 
 
m
 
l Reporter Lysis buffer (Pro-
mega) for 15 min at room temperature. Luciferase activity was
quantified by adding 10 
 
m
 
l of the lysate to 50 
 
m
 
l of luciferase
assay substrate (Promega) and immediately measured with a
GenProbe Leader™ 1 luminometer (Wallac Inc.). To normalize
for variations in transfection efficiency, luciferase activities in dif-
ferent transfection conditions were expressed as a percentage
of maximal NF-AT responses determined by treating cells with
50 ng/ml PMA and 1 
 
m
 
M ionomycin as previously described
(18, 20).
 
Results
 
Identification of GrpL, a New Member of the Grb Family of
Adaptor Proteins.
 
Through random sequencing of cDNA
clones in a library prepared from the acute myelogenous
leukemia cell line KG-1a, we identified a cDNA encoding
a 330-amino acid polypeptide with a predicted molecular
weight of 
 
z
 
37 kD. The linear amino acid sequence of this
polypeptide organizes into an NH
 
2
 
-terminal SH3 domain
followed by an SH2 domain, a proline-rich region, and
finally a COOH-terminal SH3 domain (Fig. 1 A). A com-
parison to other known proteins available in current se-
quence data banks revealed that this protein is most similar to
the adaptor proteins, Grb2 and Grap (Fig. 1 B and Table I).
Based on this similarity, we have designated this molecule,
GrpL for Grb2-related protein of the lymphoid system (see
below). Using RT-PCR and a combination of 5
 
9
 
- and
3
 
9
 
-RACE (Materials and Methods), we also isolated the
full-length cDNA encoding the murine homologue of GrpL.
Human and murine GrpL are highly conserved proteins
sharing 
 
.
 
90% identity in the SH3 and SH2 domains (Ta-
ble I). The least conserved area is the proline-rich region
with 
 
z
 
74% identity (Table I). Amino acid sequence align-
ment between hGrpL, Grb2, and Grap revealed that hGrpL
is 38–56% identical to Grb2 and Grap in the SH3 and SH2
domains (Fig. 1 B, Table I). This conservation is slightly less
than that between Grb2 and Grap (49–68%; reference 33).
The biggest difference between GrpL and Grb2 or Grap is
the presence of a proline-rich region between the SH2 and
COOH-terminal SH3 domain. This proline-rich region
could potentially be bound by SH3 domain–containing
proteins found in other adaptor molecules (36, 37). Taken
together, the amino acid composition of GrpL suggests that
it may interact with different proteins in lymphocytes when
compared with Grb2 or Grap.
 
Transcripts of GrpL Are Selectively Expressed in Hematopoietic
Tissues and in B and T Lymphocytes.
 
The transcripts for Grb2
are expressed ubiquitously in mammalian species (38),
whereas Grap mRNA is expressed at considerably higher
levels in lymphoid tissues than in other tissues (33, 34).
Northern blot analysis of mRNA isolated from different
human tissues demonstrated that the transcripts for GrpL
are relatively restricted to hematopoietic tissues. Thus,
transcripts of 1.4 kb and 3–3.5 kb were detected in lymph
node, bone marrow, spleen, thymus, and peripheral blood
lymphocytes, as well as weakly in testis, but not in stomach,
thyroid, spinal cord, trachea, adrenal gland, prostate, ovary,
or small intestine (Fig. 2 A). Probing total RNA from a
panel of cell lines by Northern blot analysis and RT-PCR
further confirmed the restricted expression pattern of GrpL
(Fig. 2, B and C). GrpL transcripts were detected in the
myeloid and erythroid progenitor cell lines KG-1a and
K562, respectively, but not in the myeloid cell line HL60.
In T cells, GrpL is expressed in the Jurkat, Molt-4, HSB-2,
CEM, and HPB-ALL lines, but not in the HuT78 line. Inter-
estingly, of all the B cell lines examined, GrpL transcripts
were only found in EBV-transformed lymphoblastoid cell
lines including T5-1, HCLL7678, CESS, F4, FBM2-4, and
IM9. Other B cell lines, including the Burkitt’s lymphomas
(Daudi, BJAB, and Ramos), the pre-B cell lines (REH,
NALM-6, and BLIN1), the sIgM
 
1
 
 early B cell lines (BLIN1
and 1E8), and the myeloma cell line RPMI8226, did not
express any GrpL transcripts. Results from the above ex-
periments show that GrpL expression is highly regulated and
restricted to subsets within hematopoietic lineages.
 
GrpL Associates with SLP-76 in T Cells.
 
To characterize
the GrpL protein and the proteins with which it interacts, 
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we generated a rabbit hetero-antiserum specific for GrpL
by immunizing with a His-Tag GrpLSH2 fusion protein.
This antiserum can specifically immunoprecipitate from Jur-
kat T cells two proteins 
 
z
 
38 and 40 kD in size (Fig. 3 A).
Both proteins were detectable by Western blot analysis of
either GrpL immunoprecipitates (IPs) or whole cell lysates.
This antiserum does not cross-react with Grb2, which runs
at a lower molecular weight on gels (Fig. 3 A and see Fig.
5), and by all criteria it appears to be specific for GrpL.
To detect proteins potentially capable of interacting with
GrpL, we pharmacologically stimulated Jurkat cells with
pervanadate, immunoprecipitated GrpL, and then Western
blotted with either antiphosphotyrosine or anti-GrpL sera
(Fig. 3 B). 2–5 min after stimulation, a major tyrosine phos-
phorylated protein 40 kD in size and a minor 38-kD phos-
phoprotein were detectable in anti-GrpL but not control
serum IPs. This doublet most likely corresponds to GrpL
itself, which migrates to the same position on gels (Fig. 3,
A and B); it is possible that these bands represent differen-
tially phosphorylated forms of GrpL. Compared with per-
vanadate, TCR ligation induced only weak tyrosine phos-
phorylation of GrpL (data not shown).
Figure 1. Structural organization
of GrpL and amino acid homology
comparison with other Grb2-like
proteins. A schematic for the do-
main organization of GrpL is de-
picted in the upper part of A. Num-
bers on top mark amino acid
residues at the boundaries of the dif-
ferent domains. The lower part of A
shows the amino acid sequence
comparison between mouse and hu-
man GrpL and B shows the amino
acid sequence comparison among
mGrpL, hGrpL, Grb2, and Grap.
Boxed residues represent homolo-
gous regions. Amino acids in bold
and shade denote identical residues,
while unshaded amino acids denote
conserved substitutions. The nucle-
otide sequences for hGrpL and
mGrpL are available from EMBL/
GenBank/DDBJ under accession
numbers AF129476 and AF129477. 
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In addition to the 38–40-kD doublet, a second major ty-
rosine phosphorylated protein 
 
z
 
68–70 kD in size was also
detected in the GrpL IP after pervanadate treatment (Fig. 3,
B and C). In T cells, substrates for protein tyrosine kinases
in this size range include SLP-76, SHP-2, Syk, and ZAP-
70. Indeed, in the GrpL IP obtained from both unstimu-
lated and pervanadate-stimulated Jurkat cells, we were able
to detected SLP-76 (Fig. 3 C) but not ZAP-70 (data not
shown). However, the amount of SLP-76 associating with
GrpL remained relatively unchanged after stimulation. More-
over, the SLP-76 molecule coimmunoprecipitated with
GrpL before stimulation showed an almost undetectable
level of tyrosine phosphorylation (Fig. 3 C). These results
are consistent with the idea that GrpL can interact with
SLP-76 independently of tyrosine phosphorylation as has
been suggested for Grb2 and SLP-76 (21, 27). The in-
creased signal of the 68–70-kD molecule coimmunopre-
cipitated with GrpL after stimulation may be a conse-
quence of increased tyrosine phosphorylation of SLP-76
and/or the recruitment of additional tyrosine phosphory-
lated proteins of the same size to GrpL. In the SLP-76 IP
obtained from pervanadate-stimulated Jurkat cells, we
could also detect tyrosine-phosphorylated protein at 38–
40, 50–55, and 110 kD (Fig. 3 C).
 
GrpL and Grb2 Interact with Different Molecules.
 
To exam-
ine the possibility of distinct functional roles played by dif-
ferent Grb2-like molecules in T cells, we asked whether
GrpL and Grb2 interact with different proteins. We immu-
noprecipitated either GrpL or Grb2 from Jurkat cells and
probed for associating proteins. SLP-76 was detected in
GrpL IPs (Fig. 4 A), as also shown in Fig. 3 C. However,
we could not detect any SLP-76 associating with Grb2.
Consistent with this was the presence of GrpL but not
Grb2 in the SLP-76 IPs (Fig. 4 A). On the other hand, we
were able to detect Sos1 and Sos2, GEFs of Ras, in Grb2
IPs (Fig. 4 B), as has been reported in other cell systems.
Interestingly, no detectable Sos1 or Sos2 was found to be
coimmunoprecipitated with GrpL (Fig. 4 B). These results
suggest that in Jurkat T cells, GrpL preferentially complexes
with SLP-76, whereas Grb2 preferentially complexes with
Sos1 or Sos2.
Since both Grb2 (10–14) and Grap (33, 34) can associate
with tyrosine-phosphorylated LAT/pp36/38 upon TCR
ligation, we asked whether GrpL could also associate with
tyrosine-phosphorylated LAT/pp36/38. Jurkat cells were
stimulated by anti-CD3, and LAT/pp36/38 was immuno-
precipitated from NP-40 Jurkat cell lysates at various time
points after stimulation. As reported before (24), tyrosine-
Figure 2. Expression of GrpL transcripts. Multiple tissue blots (Clontech)
containing 2 mg per lane of polyA1 RNA (A) or blots containing 30 mg per
lane of total RNA isolated from various hematopoietic cell lines (B) were
probed with full-length GrpL. Blots were stripped and reprobed with b-actin
to monitor RNA loading. (C) RT-PCR using conditions and an hGrpL
primer as described in Materials and Methods was conducted on a subset of
cell lines in B and additional cell lines to confirm and extend results obtained
by Northern blot analysis. A primer set amplifying G3DPH was used to mon-
itor RNA loading.
 
Table I.
 
Amino Acid Sequence Comparison among hGrpL, 
mGrpL, Grb2, and Grap
 
SH3N SH2
Proline-rich
interdomain SH3C
hGrpL/mGrpL 91 93 74 94
hGrpL/Grb2 52 56
 
,
 
55 0
hGrpL/Grap 50 56
 
,
 
53 8
Numbers represent the percentage of identity between the different
domains of the two proteins listed on the lefthand column. 
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Figure 4. GrpL and Grb2 interact with
different effector molecules. (A) NP-40
lysates prepared from Jurkat cells were
immunoprecipitated with anti–SLP-76
(aSLP-76), anti-GrpL (aGrpL), anti-Grb2
(aGrb2), normal goat Ig (gIg), or normal
rabbit Ig (rIg). IPs were resolved on re-
ducing SDS-PAGE and immunoblotted
with antisera as indicated on the left. (B)
NP-40 lysates prepared from Jurkat cells
were immunoprecipitated with anti–
SLP-76 (aSLP-76) anti-GrpL (aGrpL),
anti-Sos1 (aSos1), anti-Sos2 (aSos2), or
normal rabbit Ig (rIg). IPs were resolved
on reducing SDS-PAGE and immuno-
blotted with antisera as indicated on the
right.
phosphorylation of LAT/pp36/38 increased dramatically
after TCR ligation, and started to decline after 3 min of
stimulation. This was correlated with the appearance of
Grb2 in the LAT/pp36/38 IPs (Fig. 5). However, although
the levels of GrpL proteins in NP-40 Jurkat cell lysates re-
mained unchanged throughout stimulation, we consistently
did not detect any GrpL associating with LAT/pp36/38 in
these lysates (Fig. 5).
GrpL Regulates NF-AT Activation in T Cells. Since SLP-76
has been shown to regulate NF-AT activation in T cells
(18, 20, 39), we investigated whether GrpL could play a
role in this pathway. NF-AT activation was monitored by
the expression of a NF-AT luciferase reporter construct in
Jurkat cells. As described before, overexpression of SLP-76
by cotransfection of a SLP-76 expression vector augmented
the anti-CD3–induced NF-AT activation (18, 20, 39). Over-
expression of GrpL alone consistently augmented anti-CD3–
induced NF-AT activation (Fig. 6). Moreover, an additive
effect between GrpL and SLP-76 on NF-AT activation was
observed when both were overexpressed in Jurkat cells.
The SH2 Domain of GrpL Recognizes Tyrosine-phosphory-
lated Protein Tyrosine Phosphatase SHP-2 In Vitro. Since var-
ious SH2 domains can interact with a wide spectrum of
tyrosine-phosphorylated targets, we tested to which tyro-
sine-phosphorylated protein(s) the SH2 domain of GrpL
could bind. When the GST/GrpLSH2 fusion protein was
used to probe pervanadate-stimulated Jurkat cells, tyrosine-
phosphorylated proteins that migrated at 36, 69, and 71 kD
Figure 3. Biochemical charac-
terization of GrpL. (A) Jurkat cell
lysates were immunoprecipitated
with an antiserum against GrpL
generated by immunizing rabbits
with the GST/GrpLSH2 fusion
protein or preimmune serum. IPs
were resolved along with whole
cell lysate on reducing SDS-
PAGE and immunoblotted with
the same anti-GrpL serum. (B)
Jurkat cells were stimulated for
either 2 or 5 min with pervana-
date as described in Materials and
Methods. NP-40 lysates were im-
munoprecipitated with anti-GrpL
or preimmune serum and immu-
noblotted with the antiphospho-
tyrosine antibody 4G10 (aPY).
The amounts of GrpL in different
lanes were monitored by immu-
noblotting with anti-GrpL (aGrpL).
The open arrow indicates a pre-
dominant tyrosine-phosphorylated protein coimmunoprecipitating with GrpL, and the closed arrow indicates the mobility of GrpL. (C) NP-40 lysates
prepared from unstimulated (2) or pervanadate-stimulated (1) Jurkat cells were immunoprecipitated with anti–SLP-76 (aSLP-76), anti-GrpL (aGrpL),
or normal goat or rabbit control Ig. IPs were resolved on SDS-PAGE and immunoblotted with either antiphosphotyrosine or anti–SLP-76. The arrows
indicate phosphoproteins migrating at the sizes of SLP-76 and GrpL.1249 Law et al.
could be readily detected (Fig. 7 A). In some experiments,
we also detected 95- and 130-kD tyrosine-phosphorylated
proteins. The GST/GrpLSH2 fusion protein also precipi-
tated a similar pattern from lysates prepared from anti-
CD3–stimulated Jurkat cells (Fig. 7 A). By analogy to Grb2
(24), these proteins could be LAT, ZAP-70, SHP-2, Vav,
and perhaps c-Cbl. As shown in Fig. 7 B, we were able to
confirm that SHP-2 was among the phosphoproteins pre-
cipitated by the GST/GrpLSH2 fusion protein from pervan-
adate-activated Jurkat cells. Although tyrosine-phosphory-
lated SLP-76 also migrates at z70 kD, we consistently did
not detect any SLP-76 precipitated by GST/GrpSH2.
Discussion
Critical functions are played by a variety of adaptor mol-
ecules in linking receptor proximal signal transduction
events such as activation of receptor-associated kinases to
downstream effector molecules. In this report, we describe
the identification and characterization of a new member of
the Grb family of adaptor proteins. GrpL shares similar
structural organization as Grb2 and Grap. A distinguishing
feature of GrpL not found in Grb2 or Grap is the presence
of a 100-amino acid stretch connecting its SH2 and SH3C
domains. Although this region is the least conserved be-
tween mGrpL and hGrpL, it does contain multiple proline
and glutamine residues at conserved positions (Fig. 1 and
Table I). Thus, two PxxP motifs are found in both hGrpL
and mGrpL. In hGrpL, they are P191TLP and P202QPP;
in mGrpL, they are P190LGP and P210QPP. These poly-
proline motifs conform to the consensus sequence recog-
nized by different SH3 domains (36, 37). Accordingly, it is
likely that the proline residues in GrpL do constitute a pro-
line-rich domain capable of interacting with as yet to be
defined SH3-containing proteins.
In contrast to the broadly expression Grb2, GrpL expres-
sion is restricted to hematopoietic cells (Fig. 2). In this re-
gard, GrpL is similar to Grap that transcripts for both are
found at much higher levels in hematopoietic tissues (33,
34). Although Grap is preferentially expressed in blood
cells, little is known about its expression in different stages
of T and B cell maturation or in different lymphocyte sub-
sets. GrpL transcripts are expressed at lower levels in the
bone marrow than in the secondary lymphoid organs. Im-
portantly, the highest levels of GrpL transcripts were de-
tected in the thymus (Fig. 2 A), suggesting that GrpL may
play a crucial role in regulating early T cell development.
Northern blot analysis on cell lines also demonstrates that
GrpL transcripts are not expressed in all lymphocytes (Fig.
2, B and C), suggesting that their expression may be modu-
Figure 5. GrpL does not in-
teract with LAT/pp36/38. NP-40
lysates were prepared from anti-
CD3–stimulated Jurkat cells and
were immunoprecipitated with
anti-LAT/pp36/38. Normal rab-
bit Ig (rIg) was used as the nega-
tive control. The anti-LAT/
pp36/38 IPs were resolved by
reducing SDS-PAGE on repli-
cate gels and immunoblotted
with anti-LAT/pp36/38 (aLAT/
pp36/38), antiphosphotyrosine
(4G10) (aPY), anti-Grb2 (aGrb2),
and anti-GrpL (aGrpL).  Expres-
sion of GrpL in these cells during
stimulation were monitored by
immunoblotting the anti-GrpL
IPs with anti-GrpL (aGrpL).
Figure 6. GrpL regulates NF-AT activation in T cells. Jurkat T cells
were transfected in triplicate with 20 mg of the NF-AT Luc and empty
vector (pEF), pEF-GrpL, pEF–SLP-76, or a combination of pEF-GrpL
and pEF–SLP-76 at concentrations indicated in the figure. Cells were
stimulated with the anti-TCR C305 (black bars) or left unstimulated in
medium (white bars). Luciferase activities were then determined on each
transfected cell population. The maximal NF-AT responses for the various
transfection conditions were determined by treatment with PMA plus
ionomycin, and did not differ significantly. The effects of overexpressing
GrpL and/or SLP-76 are shown as percentage of the maximal NF-AT
responses for each transfection conditions. The data are representative of
four independent experiments.1250 Novel Adaptor Molecule That Regulates NF-AT Activation
lated during lymphocyte ontogeny by specific signals. To test
this possibility, we fractionated normal B cells into subsets
and measured levels of GrpL transcripts. A clear difference
was observed in GrpL transcript expression in naive but not
in germinal center B cells (Solow, S.A., A.J. Marshall, T.J.
Yun, M.K. Ewings, and E.A. Clark, manuscript in prepa-
ration). To elucidate the signals involved in switching the
expression of GrpL on and off will provide further insights
into the functions of GrpL and its associating proteins at
different stages of lymphocyte development.
We have identified one of the GrpL-interacting proteins
to be SLP-76 (Figs. 3 and 4). Interaction between GrpL
and SLP-76 appears to be constitutive, since it could be de-
tected in both stimulated and unstimulated T cells (Figs. 3
and 4 A). Accordingly, this interaction may not require the
tyrosine phosphorylation of either SLP-76 or GrpL. In
support of this, results presented in Fig. 3 C show that
the amount of SLP-76 coimmunoprecipitating with GrpL
remained relatively constant, although SLP-76 became
heavily tyrosine-phosphorylated after pervanadate treatment.
Hence, our data argue against the possibility that the SH2
domain of GrpL mediates its interaction with SLP-76.
Grb2 has been reported to be an adaptor molecule capable
of associating with SLP-76 (24). In these studies, GST fu-
sion proteins containing Grb2 or Grb2 SH3 domains rec-
ognized SLP-76 from lysates of resting or activated T cells
independent of its tyrosine-phosphorylation (21, 27). Using
deletional mutants of SLP-76, the Grb2 binding site was
subsequently mapped to the central proline-rich region of
SLP-76 from amino acid residues 224–244 (21). These re-
sults implicate the SH3 domain of Grb2 to be the primary
mediator for interaction. Based on the similar structure be-
tween GrpL and Grb2 and the phosphorylation-indepen-
dent interaction between GrpL and SLP-76, it is likely that
the SH3 domain(s) of GrpL also mediates its interaction
with SLP-76. Experiments are currently in progress to ex-
amine this possibility.
Several recent studies have provided strong evidence for
an essential function served by SLP-76 in T lineage cells.
Biochemical experiments show that SLP-76 can interact
with both positive and negative regulators. TCR ligation
induces ZAP-70 to phosphorylate SLP-76 at three NH2-
terminal tyrosine residues (20, 30, 39). Once phosphory-
lated on its NH2-terminal tyrosine residues, in particular
Y113 and Y128, SLP-76 can be bound by the SH2 domain
of Vav (18, 19). Overexpression of SLP-76 augment IL-2
promoter activity (21), and SLP-76 also acts synergistically
with Vav to augment IL-2 promoter activity (18). More-
over, the biological activity of SLP-76 is absolutely depen-
dent on an intact proline-rich region, and hence, an inter-
action with adaptor proteins containing SH3 domain(s)
(21). On the other hand, the COOH-terminal SH2 do-
main of SLP-76 binds to a 130-kD tyrosine-phosphory-
lated protein (40, 41). This protein has been cloned, desig-
nated to be SLAP-130/Fyb, and may be involved in
downregulating the activating function of SLP-76 on the
IL-2 promoter (41). The most compelling evidence to ar-
gue for an indispensable in vivo function of SLP-76 in T
lineage cell is provided by the recent gene targeting experi-
ments. SLP-762/2 mice are characterized by an early arrest
in T cell development. CD41/CD81, CD41, and CD81 thy-
mocyte populations are completely absent from thymuses
of SLP-76 knockout mice, resulting in a corresponding
lack of peripheral T cells (22, 23). In the SLP-762/2 mice,
TCR-b chain genes appear to undergo normal rearrange-
ment and exogenous anti-CD3 fails to drive the generation
of double positive cells. Therefore, it is proposed that
the absence of SLP-76 may render the pre-TCR complex
fail to deliver maturational signals to developing T cells
(22, 23).
Our observation that GrpL associates with SLP-76 in
vivo suggests GrpL plays a pivotal role in TCR-mediated
signal transduction cascades. Studies from different labora-
tories have convincingly demonstrated binding of recombi-
nant Grb2 or Grb2 SH3 domains to SLP-76 both in cell
lysates and on Western blots (9, 21, 27), but the presence of
SLP-76 in Grb2 IPs and vice versa have not been reported
thus far. Our data argue that SLP-76 is more likely to asso-
ciate with GrpL than Grb2 under physiological conditions
in T cells (Fig. 4). This GrpL/SLP-76 association may reg-
ulate signaling pathway(s) involving SLP-76 in T cells. One
downstream target for SLP-76 is NF-AT. SLP-76 and Vav
can synergistically enhance anti-CD3–induced NF-AT ac-
tivation in T cells (18). Results in Fig. 6 demonstrate that
overexpression of GrpL alone is sufficient to enhance the
Figure 7. The SH2 domain of GrpL interacts with SHP-2. (A) Jurkat
T cells were stimulated with 10 mg/ml of anti-CD3 (aCD3) or pervana-
date for 5 min. Control cells were treated with either isotype-matched
control IgG or medium alone. NP-40 lysates were precipitated with ei-
ther GST or GST/GrpLSH2, resolved on reducing SDS-PAGE, and im-
munoblotted with the antiphosphotyrosine antibody 4G10. Arrows indi-
cates major tyrosine-phosphorylated proteins detected in the GST/
GrpLSH2 precipitates. (B) Replicate precipitates obtained from pervana-
date-stimulated Jurkat cells were immunoblotted with anti–SLP-76.1251 Law et al.
TCR-induced NF-AT. More importantly, GrpL cooper-
ated with SLP-76 in this pathway as suggested by the addi-
tive effect upon overexpression of both GrpL and SLP-76.
Given the functions of SLP-76 in regulating T cell devel-
opment and gene expression through its interaction with
the GEF Vav, we propose that GrpL may also modulate the
guanine nucleotide exchange activity of Vav via its associa-
tion with SLP-76 to regulate T cell development and func-
tions. By contrast, Grb2 may function principally via the
Sos1 and Sos2 GEFs.
Another feature that further distinguishes GrpL from
Grb2 is the lack of association between GrpL and tyrosine-
phosphorylated LAT/pp36/38 in NP-40 lysates prepared
from TCR-activated T cells (Fig. 5). Detergent-insoluble
membrane subdomains known as glycolipid-enriched mi-
crodomains or detergent-insoluble rafts concentrated with
lipid-linked signaling proteins have been proposed to be
focal areas from which receptor-mediated signaling origi-
nates (42–44). Recently, components of the activation TCR
complex, including tyrosine-phosphorylated LAT, have
been localized to such detergent-insoluble rafts, and disrup-
tion of these rafts inhibits signaling via the TCR (45, 46).
Since GrpL appears to be an integral part of the TCR-medi-
ated NF-AT activation pathway (Figs. 4–6), it is possible
that GrpL may also be localized to rafts upon TCR liga-
tion. This may allow GrpL to interact with upstream mole-
cules activated by the TCR, including tyrosine-phosphory-
lated LAT in rafts. Experiments are now in progress to
examine this possibility.
The in vitro binding of GrpLSH2 domain to tyrosine-
phosphorylated SHP-2 suggests that SHP-2 may potentially
interact with GrpL (Fig. 6). However, we have not yet de-
tected an in vivo association between GrpL and SHP-2 in
activated T cells (data not shown). SHP-2 possesses the
dual functions of either potentiating or inhibiting signal
transduction depending on the receptor system involved.
For example, SHP-2 has been shown to be required for
coupling receptors to the activation of the MAPK pathway
(47, 48). In T cells, SHP-2 interacts with CTLA-4, which
is believed to be the mechanism whereby CTLA-4 down-
regulates T cell activation, possibly via dephosphorylation
of Shc (49). Nevertheless, a recent report suggests that
SHP-2 may also be a positive regulator of TCR-mediated
signaling. Thus, a multimeric complex involving Grb2,
LAT/pp36/38, SHP-2, and a 110-kD tyrosine-phosphory-
lated protein has been reported in T cells (50). Interest-
ingly, expression of a SHP-2 mutant devoid of phosphatase
activity inhibits the TCR-induced MAPK pathway activa-
tion. Similar to Grb2, the SH2 domain of GrpL mediates
binding to SHP-2. This binding is dependent on T cell ac-
tivation and tyrosine phosphorylation of SHP-2 (Fig. 7).
Hence, after TCR ligation, the interaction between Grb2
and SHP-2 may facilitate the redistribution of the GrpL–
SLP-76 complex to the plasma membrane. Consequently,
SLP-76 would become available for phosphorylation by
ZAP-70 to generate the Vav binding sites.
Taken together, our data support a model in which dis-
tinct complexes of Grb2/Sos1/Sos2 and GrpL–SLP-76
may be responsible for connecting the TCR to the Ras-
and Rho/Rac/CDC42-mediated effector pathways, respec-
tively (Fig. 8). Thus, Grb2 is the primary adaptor molecule
responsible for the recruitment of the GEFs Sos1 and Sos2
for Ras (26) to LAT/pp36/38. The lymphoid-restricted,
Grb2-like adaptor protein Grap can also serve a similar
function by interacting with Sos and Ras (33, 34). Recruit-
ment of Ras to the inner plasma membrane activates distal
MAPKs including Erk1 and Erk2 (26). On the other hand,
Vav, a GEF for the Rho/Rac/CDC42 family of GTP-bind-
ing proteins expressed in lymphoid cells (51, 52), binds to ty-
rosine-phosphorylated SLP-76 via its SH2 domain (9), and
regulates NF-AT activation (18) and cytoskeletal reorganiza-
tion in T cells (53). Since GrpL associates with SLP-76 and
regulates NF-AT activation (Figs. 3–6), one testable possibil-
ity is that a trimolecular interaction among SLP-76, Vav, and
GrpL may be required for optimal NF-AT activation and re-
organization of cytoskeleton during T cell activation.
During the course of this study, two other groups inde-
pendently identified the same gene and protein as we de-
scribe herein, which they have designated as Mona (54)
and Gads (55, 56). In vitro data suggest that in nonlym-
phoid cells, GrpL (Mona/Gads) may interact with either the
M-CSF receptor, c-fms (54), or with c-kit (55). In agree-
ment with our results, Liu et al. (56) independently found
that GrpL can bind to SLP-76 and together with SLP-76 can
promote the activation of NF-AT in T cells. We have re-
cently identified another adaptor protein, BAM-32, which
unlike GrpL (Fig. 6 and reference 56), SLP-76 (18-21), or the
B cell adaptor BLNK (57), inhibits the activation NF-AT
(Marshall, A.J., H. Niiro, T.J. Yun, and E.A. Clark, manu-
script in preparation). Thus, antigen receptor–induced acti-
vation of NF-AT in lymphocytes is carefully regulated by
adaptor proteins.
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Figure 8. A model for how
GrpL may function in TCR-
mediated signal transduction. Re-
sults from our study demonstrate
that GrpL and Grb2 may dif-
ferentially associate with SLP-76,
LAT/pp36/p38, and Sos1/2, re-
spectively. The preferential in-
teraction between GrpL and
SLP-76 suggests that GrpL may
play a role in the regulation
NF-AT pathway during TCR-
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